SynthesisJournal of cancer research and clinical oncology2021

Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis.

Michal Sternschuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.